A crisis in clinical research.
J Immunother Cancer
; 12(7)2024 Jul 11.
Article
in En
| MEDLINE
| ID: mdl-38991727
ABSTRACT
The clinical research pipeline is critical to ensuring continued development of novel treatments that can offer patients with cancer safe and effective options. Unfortunately, progress has slowed since the COVID-19 pandemic due to uncovered, systemic inefficiencies across critical processes. Towards initiating discussion on how to reinvigorate clinical research, the Society for Immunotherapy of Cancer (SITC) hosted a virtual summit that characterized issues and formed potential solutions. This commentary serves to highlight the crisis facing clinical research as well as stimulate field-wide discussion on how to better serve patients into the future.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomedical Research
/
SARS-CoV-2
/
COVID-19
/
Immunotherapy
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
J Immunother Cancer
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: